News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
22,943 Results
Type
Article (1240)
Press Release (21703)
Multimedia
Podcasts (9)
Webinars (3)
Section
Business (6643)
Career Advice (68)
Deals (1261)
Drug Delivery (2)
Drug Development (4005)
Employer Resources (6)
FDA (710)
Job Trends (661)
News (12454)
Policy (927)
Tag
Academia (96)
Accelerated approval (1)
Adcomms (1)
Allergies (5)
Alliances (1292)
ALS (8)
Alzheimer's disease (47)
Antibody-drug conjugate (ADC) (5)
Approvals (699)
Artificial intelligence (7)
Autoimmune disease (2)
Bankruptcy (13)
Best Places to Work (585)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (1)
Bladder cancer (3)
Brain cancer (2)
Breast cancer (15)
Cancer (88)
Cardiovascular disease (17)
Career advice (51)
CAR-T (1)
Cell therapy (14)
Cervical cancer (2)
Clinical research (3419)
Collaboration (17)
Compensation (18)
COVID-19 (82)
CRISPR (2)
C-suite (6)
Cystic fibrosis (4)
Data (134)
Depression (6)
Diabetes (15)
Diagnostics (222)
Digital health (1)
Diversity, equity & inclusion (3)
Drug discovery (5)
Drug pricing (1)
Duchenne muscular dystrophy (16)
Earnings (3182)
Editorial (4)
Employer resources (6)
Events (4148)
Executive appointments (22)
FDA (766)
Funding (20)
Gene editing (4)
Generative AI (1)
Gene therapy (15)
GLP-1 (34)
Government (107)
Grass and pollen (1)
Healthcare (553)
Huntington's disease (4)
IgA nephropathy (2)
Immunology and inflammation (4)
Infectious disease (90)
Inflammatory bowel disease (6)
Influenza (2)
Intellectual property (5)
Interviews (13)
IPO (600)
IRA (2)
Job creations (112)
Job search strategy (48)
Kidney cancer (2)
Layoffs (15)
Leadership (1)
Legal (170)
Liver cancer (5)
Lung cancer (9)
Lymphoma (4)
Manufacturing (6)
MASH (3)
Medical device (458)
Medtech (458)
Mergers & acquisitions (672)
Metabolic disorders (33)
Multiple sclerosis (2)
Neurodegenerative disease (7)
Neuropsychiatric disorders (3)
Neuroscience (77)
NextGen: Class of 2025 (253)
Non-profit (148)
Northern California (138)
Obesity (16)
Opinion (6)
Pain (8)
Pancreatic cancer (8)
Parkinson's disease (5)
Patents (15)
Patient recruitment (7)
Peanut (2)
People (1919)
Pharmaceutical (1)
Phase I (825)
Phase II (1463)
Phase III (1342)
Pipeline (55)
Policy (15)
Postmarket research (152)
Preclinical (332)
Prostate cancer (4)
Psychedelics (8)
Radiopharmaceuticals (7)
Rare diseases (15)
Real estate (127)
Recruiting (3)
Regulatory (731)
Reports (1)
Research institute (76)
Resumes & cover letters (12)
Rett syndrome (3)
RNA editing (1)
RSV (3)
Schizophrenia (9)
Series A (4)
Southern California (72)
Special edition (3)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (88)
Stomach cancer (1)
Supply chain (1)
Tariffs (2)
The Weekly (9)
United States (1007)
Vaccines (34)
Venture capitalists (2)
Weight loss (3)
Date
Last 7 days (24)
Last 30 days (118)
Last 365 days (1454)
2025 (387)
2024 (1546)
2023 (1786)
2022 (2050)
2021 (2327)
2020 (2086)
2019 (1603)
2018 (1211)
2017 (1156)
2016 (965)
2015 (1547)
2014 (927)
2013 (532)
2012 (594)
2011 (558)
2010 (584)
Location
Africa (36)
Alabama (2)
Alaska (1)
Asia (929)
Australia (241)
California (263)
Canada (85)
China (6)
Colorado (10)
Connecticut (10)
Delaware (25)
Europe (2896)
Florida (49)
Georgia (7)
Illinois (24)
Indiana (13)
Japan (4)
Maine (4)
Maryland (32)
Massachusetts (189)
Michigan (2)
Minnesota (11)
Missouri (2)
Montana (3)
New Hampshire (3)
New Jersey (99)
New York (119)
North Carolina (24)
North Dakota (1)
Northern California (138)
Ohio (4)
Pennsylvania (89)
Rhode Island (2)
South America (38)
Southern California (72)
Tennessee (4)
Texas (21)
Utah (1)
Virginia (2)
Washington D.C. (1)
Washington State (13)
Wisconsin (1)
22,943 Results for "mc10".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics
Hyphens Pharma International Limited is pleased to announce that its subsidiary, Hyphens Pharma Pte. Ltd., has entered into an exclusive license, supply and commercialisation agreement with MC2 Therapeutics for the exclusive rights to register and commercialise Wynzora® Cream and all future product extensions and/or improvements for the topical treatment of plaque psoriasis in the 10 ASEAN countries.
March 12, 2024
·
5 min read
Business
MC10 and University of Vermont Announce Partnership to Advance Understanding of Gait Abnormalities in Movement Disorders
MC10, Inc., the developer of BioStamp nPoint, an end-to-end system for physiological data collection and analytics, announced today a collaboration with the University of Vermont, a leading academic research institution.
October 24, 2019
·
3 min read
Business
MC10, Inc. Announces Collaboration with University of Rochester: Development Novel Digital Biomarkers for Central Nervous System Diseases
MC10, Inc., creators of the innovative wearable device BioStamp nPoint, and the University of Rochester announced today a collaboration on advancing methods of assessing Central Nervous System (CNS) diseases
October 2, 2019
·
3 min read
Business
MC10, Inc. Announces Collaboration with Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago: Innovating Precision Medicine Approaches to Improve Maternal-Infant Outcomes
This collaboration bridges MC10’s expertise in wearable health solutions, DevSci’s leading-edge research on how the prenatal environment shapes early brain and behavioral development, and Lurie Children’s expertise in research at the maternal-fetal interface.
October 16, 2019
·
5 min read
Business
MC10 Enters Strategic Collaboration With LabCorp, Including Equity Investment, to Advance Clinical Trial Innovation and Healthcare Diagnostics
As part of the collaboration, LabCorp has also made an equity investment into MC10.
November 1, 2017
·
3 min read
Press Releases
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
April 14, 2025
·
3 min read
Press Releases
TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138
March 28, 2025
·
6 min read
Press Releases
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer
April 2, 2025
·
5 min read
Drug Development
MC10 Announces the Use of BioStamp nPoint® in Phase III Study of Huntington Disease
The study is sponsored by Neurocrine Biosciences and conducted in collaboration with the Huntington Study Group.
November 13, 2019
·
2 min read
Press Releases
TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial
March 14, 2025
·
6 min read
1 of 2,295
Next
